We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Urine Protein Test Can Predict Dementia Risk

By LabMedica International staff writers
Posted on 26 Sep 2025

Dementia remains one of the most pressing health challenges worldwide, with age as the greatest risk factor. More...

Increasingly, research suggests that diseases in other organs, such as the kidneys, may play a role in its development. Identifying markers that link kidney health to brain function could provide an early warning for cognitive decline. Now, a new study has shown that a common protein found in urine may indicate an increased risk of developing dementia later in life.

The study, conducted by researchers at Karolinska Institutet (Stockholm, Sweden), investigated the role of albuminuria—an abnormal condition where the protein albumin leaks into urine. Normally, healthy kidneys filter waste products while keeping essential proteins like albumin in the blood. Elevated albumin levels indicate kidney damage and, according to this research, may also reflect vascular changes that predispose individuals to dementia.

Researchers followed 130,000 adults aged over 65 in Stockholm who were free of dementia at baseline. Over four years, 7 percent developed dementia. After adjusting for kidney function and other health factors, results showed that those with moderate albuminuria (30–299 mg/g) had a 25 percent higher risk of dementia, while those with high levels (≥300 mg/g) had a 37 percent greater risk compared to participants with normal albumin levels.

The association was particularly strong for vascular dementia, often caused by stroke, high blood pressure, diabetes, or vascular disease, and for mixed dementia, which combines vascular and Alzheimer’s features. The findings, published in the Journal of Internal Medicine, highlight how kidney dysfunction may mirror damage in the brain’s small vessels, influencing the blood-brain barrier and increasing the risk of harmful protein buildup linked to dementia.

The study underscores the potential of routine screening for albuminuria in older adults and in patients with conditions like hypertension, diabetes, cardiovascular disease, or kidney disease. Detecting the condition early could allow for preventive interventions to reduce or delay dementia onset. Researchers suggest integrating this simple urine test into dementia risk assessments to improve outcomes and reduce disease burden.

"These results underscore the importance of routine screening for albuminuria as part of early dementia risk assessment, especially in patients with high blood pressure, diabetes, cardiovascular disease, or kidney disease,” said Hong Xu, assistant professor at Karolinska Institutet and last author of the study. “Early detection of albuminuria could potentially delay or prevent the onset of dementia."

Related Links:
Karolinska Institutet


New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
Multi-Chamber Washer-Disinfector
WD 390
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.